Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Indivior ( (INDV) ) has issued an announcement.
Indivior PLC has been included in the U.S. Russell 2000® and 3000® Indexes, reflecting its growing presence in the U.S. market, where 85% of its net revenue was generated in 2024, primarily from its SUBLOCADE® medication for opioid use disorder. This inclusion is expected to enhance Indivior’s visibility among investment managers and institutional investors, aligning with its strategy to expand its U.S. business and increase stakeholder value.
More about Indivior
Indivior is a global pharmaceutical company focused on developing medicines to treat opioid use disorder (OUD). Headquartered in Richmond, VA, the company aims to transform OUD from a global crisis to a recognized and treated chronic disease. Indivior’s products are available in over 30 countries, and it employs over 1,000 individuals worldwide.
See more insights into INDV stock on TipRanks’ Stock Analysis page.